Sterling felt a chill run down his spine. He remembered Elena. She was a brilliant researcher who had mysteriously resigned and vanished right before the project was shut down.
But the screen did not fill with diagrams of chemical structures or lists of pharmacokinetics. Instead, the document opened to a single, centered line of text in Courier font: This is not a textbook.
Sterling’s heart skipped. He was a professor of pharmacology, but before that, he had worked in experimental drug development in the early 2010s. He knew what Project Lethe was. It was a classified, highly controversial research initiative aimed at creating a pharmaceutical compound capable of targeted memory erasure for trauma victims. It was abandoned in 2013 due to "unresolvable safety concerns." Or so the public was told. Pharmacology 4th Edition (2012) (PDF) Brenner &...
Sterling frowned. He scrolled down. The next page contained a short, dated entry from November 2012.
The file name was cut off by the edge of the window. He clicked to open it. Sterling felt a chill run down his spine
He flipped to page 342. In the margin, written in tiny, immaculate handwriting that had survived fourteen years of silence, were rows of chemical symbols and a single, desperate message: Remember for those who cannot.
Sterling sat back, breathless. He looked over at his office bookshelf. Towering among dozens of heavy medical volumes was a thick, worn-out paperback with a blue and white cover. But the screen did not fill with diagrams
He scrolled to the very end of the file, past pages of simulated medical charts and chemical chains that spelled out hidden messages. The final entry was short.